Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB26FMBFJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,303
Award facts
- Contract value 100% obligated
- $13,302.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,302.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2 pen/mL formulation on October 29, 2025, with completion targeted for October 30, 2025. This is a non-set-aside competitive award, with performance to be fulfilled at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions, and this procurement supports the military's medical supply requirements. The company's extensive track record with DLA demonstrates its capability to meet federal procurement standards through competitive contracting, with delivery orders ranging from minimal to substantial values across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FMBFJ?
SPE2DB26FMBFJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FMBFJ worth?
The government has obligated $13,303 on SPE2DB26FMBFJ.
Is contract SPE2DB26FMBFJ an order under another contract?
Yes. SPE2DB26FMBFJ is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMBFJ competed?
The extent of competition for SPE2DB26FMBFJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award